13D Filing: Paulson & Co and Valeant Pharmaceuticals International Inc. (VRX)

Page 2 of 5 – SEC Filing

1.
NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Paulson & Co. Inc.
2.
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)    [ ]
(b)    [ ]
3.
SEC USE ONLY
4.
SOURCE OF FUNDS
OO
5.
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)      [ ]
6.
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:
7.
SOLE VOTING POWER
20,839,035 (1) (2)
8.
SHARED VOTING POWER
0
9.
SOLE DISPOSITIVE POWER
20,839,035 (1) (2)
10.
SHARED DISPOSITIVE POWER
0
11.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
20,839,035 (1) (2)
12.
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11)
EXCLUDES CERTAIN SHARES    [ ]
13.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
6.0% (2)
14.
TYPE OF REPORTING PERSON
IA,
(1)
See Note 1 to Item 5 below.
(2)
Excludes cash-settled swaps disclosed in Item 6 representing economic exposure comparable to 259,500  additional shares of Common Stock (as defined below), which if aggregated with such beneficially owned shares, represent an aggregate economic interest in 21,098,535 shares representing approximately 6.1% of the outstanding shares of Common Stock.

Follow Bausch Health Companies Inc. (NYSE:BHC)